Opening the door to a new era: A dual-chamber leadless pacemaker
- PMID: 40438127
- PMCID: PMC12117376
- DOI: 10.1002/joa3.70100
Opening the door to a new era: A dual-chamber leadless pacemaker
Abstract
Dual-chamber leadless pacing with Aveir DR offers a breakthrough alternative for patients at high risk of infection or with limited vascular access. By enabling both atrial and ventricular pacing without transvenous leads, this technology improves AV synchrony and may revolutionize future cardiac rhythm management, including defibrillation and resynchronization therapies.
Keywords: Aveir; dual‐chamber; leadless pacemaker.
© 2025 The Author(s). Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society.
Conflict of interest statement
Dr. Kondo received lecture fees from Daiichi‐Sankyo, Abbott Medical Japan, Biotronik Japan, Boston Scientific, Japan Lifeline, Medtronic, and research funds from Daiichi‐Sankyo and Boston Scientific. Dr. Nakano belongs to the endowed department from Abbott Medical Japan, Biotronik Japan, and Fukuda Denshi. Dr. Kobayashi received lecture fees from Abbott Medical Japan, Bayer Japan, Bristol‐Myers Squibb, Boehringer Ingelheim, Daiichi‐Sankyo, and scholarship funds from Takeda Pharmaceutical, Abbott Medical Japan, Terumo, Otsuka Pharmaceutical, Boehringer Ingelheim, Astellas, Daiichi‐Sankyo, Win International, Japan Lifeline, and Nipro.
Figures

References
-
- Soejima K, Asano T, Ishikawa T, Kusano K, Sato T, Okamura H, et al. Performance of leadless pacemaker in Japanese patients vs. rest of the world ― results from a global clinical trial ―. Circ J. 2017;81:1589–1595. - PubMed
-
- Knops R, Reddy V, Ip J, Doshi R, Exner D, Defaye P, et al. A dual‐chamber leadless pacemaker. N Engl J Med. 2023;388:2360–2370. - PubMed